These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 33428994)

  • 1. Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.
    Chen J; Zhang X; Millican R; Sherwood J; Martin S; Jo H; Yoon YS; Brott BC; Jun HW
    Adv Drug Deliv Rev; 2021 Mar; 170():142-199. PubMed ID: 33428994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Managing Atherosclerosis via Nanomedicine.
    Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
    Small; 2018 Jan; 14(4):. PubMed ID: 29239134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the toxicological effects of nanomaterials on atherosclerosis: mechanisms involved and influence factors.
    Chen S; Su Y; Zhang M; Zhang Y; Xiu P; Luo W; Zhang Q; Zhang X; Liang H; Lee AP; Shao L; Xiu J
    J Nanobiotechnology; 2023 Apr; 21(1):140. PubMed ID: 37118804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis Treatment with Stimuli-Responsive Nanoagents: Recent Advances and Future Perspectives.
    Maruf A; Wang Y; Yin T; Huang J; Wang N; Durkan C; Tan Y; Wu W; Wang G
    Adv Healthc Mater; 2019 Jun; 8(11):e1900036. PubMed ID: 30945462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases.
    Wu Y; Vazquez-Prada KX; Liu Y; Whittaker AK; Zhang R; Ta HT
    Nanotheranostics; 2021; 5(4):499-514. PubMed ID: 34367883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis.
    Sha X; Dai Y; Song X; Liu S; Zhang S; Li J
    Int J Nanomedicine; 2021; 16():701-714. PubMed ID: 33536755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
    Qiao R; Huang X; Qin Y; Li Y; Davis TP; Hagemeyer CE; Gao M
    Nanoscale; 2020 Apr; 12(15):8040-8064. PubMed ID: 32239038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances of nanomedicine in treatment of atherosclerosis and thrombosis.
    Mao Y; Ren J; Yang L
    Environ Res; 2023 Dec; 238(Pt 2):116637. PubMed ID: 37482129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine for Atherosclerosis: Molecular Imaging and Treatment.
    Karagkiozaki V; Logothetidis S; Pappa AM
    J Biomed Nanotechnol; 2015 Feb; 11(2):191-210. PubMed ID: 26349296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
    Chen D; Dougherty CA; Zhu K; Hong H
    J Control Release; 2015 Jul; 210():230-45. PubMed ID: 25910580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomaterials to Resolve Atherosclerosis.
    Peters EB; Kibbe MR
    ACS Biomater Sci Eng; 2020 Jul; 6(7):3693-3712. PubMed ID: 33463318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials for reducing amyloid cytotoxicity.
    Zhang M; Mao X; Yu Y; Wang CX; Yang YL; Wang C
    Adv Mater; 2013 Jul; 25(28):3780-801. PubMed ID: 23722464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.
    Cheng J; Huang H; Chen Y; Wu R
    Adv Sci (Weinh); 2023 Dec; 10(36):e2304294. PubMed ID: 37897322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.